1. Sweetman, S.C., Blake, P.S., Brayfield, A., McGlashan, J.M., Neathercoat, G.C., Parsons, A.V.: Martindale: The Complete Drug References, 36th edn. pp. 539–540. Pharmaceutical Press, Gurnee (2009)
2. Richardson, M.D., Warnock, D.W.: Fungal infection—diagnosis and management. Blackwell Scientific Publications, London (1993)
3. Connors, R.D., Elder, E.J.: Using a portfolio of particle growth technologies to enable delivery of drugs with poor water solubility. Solubilization solutions. Drug Deliv. Technol. 4(8), (2004). http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=&nm=&type=Publishing&mod=Publications%3A%3AArticle&mid=8F3A7027421841978F18BE895F87F791&tier=4&id=51EA11B6268048338C15D4DD2D00C55C . Accessed 01 Sept 2010
4. Gallia, E., Nicolaides, E., Horter, D., Lobenberg, R., Reppas, C., Dressman, J.B.: Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 15, 698–705 (1998)
5. Shrum, J.P., Milikan, L.E.: Oral antifungal therapy. In: Milikan, L.E. (ed.) Drug therapy in dermatology, pp. 79–102. Markel Decker Inc, New York (2000)